Novavax vaccine dose, delivery, storage, side effects—and all the details doctors need to know with Sandra Fryhofer, MD, AMA’s liaison to the Advisory Committee on Immunization Practices (ACIP), and a member of ACIP’s COVID-19 Vaccine Workgroup. American Medical Association CXO Todd Unger hosts.
AMA COVID-19 resource center for physicians: http://ama-assn.org/covid-19
Read MoreAMA CXO Todd Unger dives into new developments from ACIP’s emergency meeting on Feb. 4 with Dr. Sandra Fryhofer, AMA’s liaison to the Advisory Committee on Immunization Practices (ACIP), and a member of ACIP’s COVID-19 Vaccine Workgroup.
Read MoreAMA CXO Todd Unger discusses news from the recent meeting of the CDC’s Advisory Committee on Immunization Practices, or ACIP, with Sandra Fryhofer, MD, AMA’s liaison to ACIP, and a member of ACIP’s COVID-19 Vaccine Workgroup. Updates include new COVID booster recommendations for teens, a shorter booster interval after a Pfizer vaccine series, new additional dose recommendations for immunocompromised children, and what you need to know about Pfizer’s new COVID vaccine formulation for adults. Also reviewing new data about preventing MIS-C (multisystem inflammatory syndrome) in children, as well as recent decision memos from the CDC director.
Read MoreAMA CXO Todd Unger discusses what physicians need to know about the recent COVID vaccine authorization for children in the 5 to 11 age group with Dr. Sandra Fryhofer, AMA’s liaison to the Advisory Committee on Immunization Practices (ACIP), and a member of ACIP’s COVID-19 Vaccine Workgroup.
Read MoreAMA CXO Todd Unger discusses what physicians need to know about boosters for Moderna, J&J recipients, and the newly approved mix-and-match strategy, with Dr. Sandra Fryhofer, AMA’s liaison to the Advisory Committee on Immunization Practices (ACIP), and a member of ACIP’s COVID-19 Vaccine Workgroup.
Read MoreAMA CXO Todd Unger talks boosters with Dr. Sandra Fryhofer, AMA’s liaison to the Advisory Committee on Immunization Practices. Learn what physicians need to know about the latest Pfizer booster authorization, including who is eligible, why boosters are needed and what this means for our larger efforts to fight the pandemic.
Read MoreDr. Sandra Fryhofer, AMA’s liaison to the Advisory Committee on Immunization Practices (ACIP), a member of ACIP’s COVID-19 Vaccine Workgroup, and chair-elect of the AMA Board of Trustees, shares details from the latest ACIP meeting, including more details on the Pfizer approval, the latest vaccine safety data and the timeline for booster shots.
Read MoreA discussion with Sandra Fryhofer, MD, chair-elect of the AMA Board of Trustees and the AMA’s liaison to the Advisory Committee on Immunization Practices, about if and when we’ll need COVID-19 vaccine boosters, the role of the dangerous Delta variant and how this all affects immunocompromised individuals.
Read MoreA discussion with Dr. Sandra Fryhofer, the AMA’s liaison to the CDC’s Advisory Committee on Immunization Practices (ACIP), who takes a closer look at the delta variant and other variants of concern. She also covers what physicians need to know about authorized COVID vaccines, including real-world effectiveness and rare adverse events.
Read MoreDr. Sandra Fryhofer, the AMA liaison to the CDC’s Advisory Committee on Immunization Practices (ACIP), discusses the committee’s recommendation to lift the pause on the Johnson & Johnson vaccine and what physicians need to know to help address patients’ concerns.
Read More
Comentarios recientes